Stmnt re Share Price Movement


 

TIDMCCGP 
 
RNS Number : 4304Q 
Claimar Care Group PLC 
09 April 2009 
 
9 April 2009? 
 
For Immediate Release 
 
 
Claimar Care Group PLC ('Claimar Care' or the 'Company') 
 
 
Strategic Review 
 
 
The board of Claimar Care Group PLC (AIM: CCGP), one of the UK's leading 
providers of health and social care solutions to people in need of care at home, 
notes today's rise in the share price of the Company. 
 
 
As a result, the board of Claimar Care confirms that it is in the early stages 
of undertaking a strategic review to consider how best to take the business 
forward. 
 
 
The strategic review has been initiated by the Board as it is disappointed with 
the Company's depressed share price which it feels does not fairly reflect the 
Company's strong market position and growth prospects. 
 
 
As part of this review, the Claimar Care Board will be considering a number of 
options available to the Company to maximise shareholder value including the 
possible sale of all or part of the business, and accordingly has appointed KPMG 
Corporate Finance as financial advisor to assist with this process. 
 
 
The strategic review is at a very early stage and the Board intends to update 
shareholders when appropriate. 
 
 
Accordingly, under the rules of the Takeover Code, Claimar Care is now in an 
offer period. Claimar Care confirms, pursuant to Rule 2.10 of the Takeover Code, 
that its issued share capital as at 9 April 2009 comprised 49,995,140 ordinary 
shares of 10 pence each. The shares are traded on AIM under ISIN GB00B0WFJP05. 
 
 
Dealing Disclosure Requirements 
 
 
Under the provisions of Rule 8.3 of the Takeover Code ('the Code'), if any 
person is, or becomes, 'interested' (directly or indirectly) in 1% or more of 
any class of 'relevant securities' of Claimar Care, all 'dealings' in any 
'relevant 
securities' of that company (including by means of an option in respect of, or a 
derivative referenced to, any such 'relevant securities') must be publicly 
disclosed by no later than 3.30 pm (London time) on the London business day 
following the date of the relevant transaction. This requirement will continue 
until the date on which the offer becomes, or is declared, unconditional as to 
acceptances, lapses or is otherwise withdrawn or on which the 'offer period' 
otherwise ends. If two or more persons act together pursuant to an agreement or 
understanding, whether formal or informal, to acquire an 'interest' in 'relevant 
securities' of Claimar Care, they will be deemed to be a single person for the 
purpose 
of Rule 8.3. 
 
 
Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant 
securities' of Claimar Care by any offeror, or by any of its respective 
'associates', 
must be disclosed by no later than 12.00 noon (London time) on the London 
business day following the date of the relevant transaction. 
 
 
A disclosure table, giving details of the companies in whose 'relevant 
securities' 'dealings' should be disclosed, and the number of such securities in 
issue, can be found on the Takeover Panel's website at 
www.thetakeoverpanel.org.uk. 
 
 
'Interests in securities' arise, in summary, when a person has long economic 
exposure, whether conditional or absolute, to changes in the price of 
securities. In particular, a person will be treated as having an 'interest' by 
virtue of the ownership or control of securities, or by virtue of any option in 
respect of, or derivative referenced to, securities. 
 
 
Terms in quotation marks are defined in the Code, which can also be found on the 
Panel's website. If you are in any doubt as to whether or not you are required 
to disclose a 'dealing' under Rule 8, you should consult the Panel. 
 
 
KPMG Corporate Finance, a division of KPMG LLP which is authorised and regulated 
by the Financial Services Authority for investment business activities, is 
acting for the Company as financial advisor in relation to the matters set out 
in this announcement and is not acting for any other person in relation to these 
matters. KPMG Corporate Finance will not be responsible to anyone other than the 
Company for providing the protections afforded to its clients or for providing 
advice in relation to the contents of this announcement. 
 
 
Arden Partners Plc which is authorised and regulated by the Financial Services 
Authority for investment business activities, is acting for the Company as 
Nominated Adviser in relation to the matters set out in this announcement and is 
not acting for any other person in relation to these matters.  Arden Partners 
Plc will not be responsible to anyone other than the Company for providing the 
protections afforded to its clients or for providing advice in relation to the 
contents of this announcement. 
 
 
ENDS 
 
 
Enquiries: 
 
 
Claimar Care Group Plc 
Mark Hales, Chief ExecutiveTel:  0121 410 4080 
 
 
Arden Partners Plc (Nominated Adviser) 
Chris Fielding                                     Tel:  0207 3981638 
Steve Douglas                                    Tel:  0121 423 8943 
 
 
KPMG Corporate Finance (Financial Advisor) 
Stephen Craik                        Tel:  0121 609 5805 
Chris Belsham                        Tel: 0161 246 4548 
 
 
Winningtons Financial 
Paul Vann/Tom Cooper            Tel: 0117 920 0092 or 07768 807 631 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 SPMZGGGDGLVGLZM
Claimar Care (LSE:CCGP)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024